Myasthenia gravis medical therapy

Jump to navigation Jump to search

Myasthenia gravis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myasthenia Gravis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myasthenia gravis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myasthenia gravis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myasthenia gravis medical therapy

CDC on Myasthenia gravis medical therapy

Myasthenia gravis medical therapy in the news

Blogs on Myasthenia gravis medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myasthenia gravis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

The mainstays of medical therapy for myasthenia gravis are:

Symptomatic treatments

Chronic immunomodulating treatments

  • glucocorticoids
  • immunosuppressive drugs
  1. Azathioprine
  2. Mycophenolate
  3. Cyclosporine
  4. Tacrolimus
  5. Rituximab
  6. Methotrexate
  7. Etanercept
  8. Cyclophosphamide

Rapid immunomodulating treatments

  • plasmapheresis
  • intravenous immune globulin

References

Template:WH Template:WS